Hernia Large biopsy 3-6 cm

Biopsy

Report in 240Hrs

At Home

No Fasting Required

Details

Tissue from hernia repair.

₹666₹951

30% OFF

Hernia Large Biopsy 3-6 cm - Comprehensive Test Guide

Why is it done?
- To obtain tissue samples from hernial sacs measuring 3-6 cm in diameter for histopathological examination
- To diagnose underlying malignancy or suspicious lesions within hernial contents or hernial sac lining
- To evaluate for occult malignancy in incarcerated or strangulated hernias
- To determine the nature of inflammatory or atypical tissue components within the hernia
- Primary indications: Palpable mass within hernia, suspicious imaging findings, rapid hernia enlargement, or pain out of proportion to hernial size
- Typically performed during surgical hernia repair or through ultrasound/CT-guided percutaneous biopsy
Normal Range
- Normal Result: Benign fatty tissue, fibroadipose tissue, or simple hernia contents consistent with bowel, omentum, or other normal abdominal organs; no malignant cells; no evidence of malignancy
- Abnormal Result: Presence of atypical cells, malignant cells, inflammatory changes, necrotic tissue, or pathological findings suggestive of malignancy
- Units of Measurement: Histopathological diagnosis (categorical); specimen size documented in centimeters (cm)
- Interpretation: Negative (benign) findings rule out malignancy; positive findings indicate need for immediate clinical intervention and possible imaging or surgical follow-up
Interpretation
- Benign/Negative Findings: No malignant cells detected; tissue consistent with normal hernia contents; patient may proceed with routine hernia repair without oncological concerns
- Malignant/Positive Findings: Presence of carcinoma, sarcoma, lymphoma, or other malignant neoplasm; requires immediate oncological consultation and potentially wider surgical margins or extended resection
- Atypical/Suspicious Findings: Cells show borderline or equivocal features; may require repeat biopsy, immunohistochemical studies, or molecular testing for definitive diagnosis
- Inflammatory/Infectious Changes: Evidence of acute or chronic inflammation, abscess formation, or infection; may indicate incarcerated or strangulated hernia requiring urgent intervention
- Factors Affecting Results: Specimen adequacy and proper fixation; location of biopsy site; timing of biopsy relative to hernia onset; presence of necrotic tissue or hemorrhage; previous radiation or chemotherapy
Associated Organs
- Primary Organ Systems: Abdominal wall, integumentary system; secondary involvement of hernia contents (bowel, omentum, mesentery)
- Associated Medical Conditions: Occult malignancy in hernia (Spiegel's hernia carcinoma, umbilical hernia malignancy); incarcerated hernia; strangulated hernia; mesh-related complications; hernia recurrence
- Diseases Diagnosed/Monitored: Adenocarcinoma, squamous cell carcinoma, liposarcoma, leiomyosarcoma, gastric or intestinal cancer, metastatic cancer within hernia, granulomatous disease, tuberculosis of abdominal wall
- Potential Complications/Risks: Bowel perforation, hemorrhage, infection if malignancy present; delay in cancer treatment; need for extended surgical resection; risk of contamination with malignant cells during biopsy
Follow-up Tests
- If Malignancy Detected: CT chest/abdomen/pelvis for staging; MRI for local extent; tumor markers (CEA, CA 19-9); multidisciplinary oncology consultation
- Immunohistochemical Studies: For atypical findings; includes tumor-specific markers, proliferation indices (Ki-67), and origin determination
- Molecular Testing: Gene sequencing, mutation analysis for therapeutic targeting; FISH testing if applicable
- Repeat Biopsy: If initial sample inadequate, non-diagnostic, or atypical findings warrant definitive diagnosis; typically within 2-4 weeks
- Clinical Imaging Follow-up: Ultrasound or CT at 3-6 months post-hernia repair to assess for recurrence or complications; annual imaging for malignancy surveillance
- Complementary Tests: Microbiological culture if infection suspected; flow cytometry for lymphoid lesions; electron microscopy if unusual tissue types identified
Fasting Required?
- Fasting Requirement: YES, if percutaneous biopsy under conscious sedation or general anesthesia
- Fasting Duration: 6-8 hours prior to procedure (NPO - Nothing by Mouth from midnight if morning procedure)
- Fluid Intake: Clear fluids may be permitted up to 2 hours prior; check facility-specific guidelines
- Medications to Avoid: Anticoagulants (warfarin, dabigatran, apixaban) typically discontinued 3-5 days before procedure; NSAIDs (aspirin, ibuprofen) stopped 5-7 days prior; discuss with physician
- Laboratory Work Prior: Coagulation studies (PT/INR, PTT), complete blood count (CBC), basic metabolic panel (BMP) may be required
- Other Preparation Requirements: Informed consent; removal of jewelry and metal objects; marking of biopsy site by clinician; patient should void bladder before procedure; arrange transportation as sedation effects may linger; Bring insurance ID and photo identification
- Post-Procedure Instructions: Resume normal diet after sedation wears off; avoid heavy lifting for 48-72 hours; monitor biopsy site for bleeding, infection, or unusual swelling; results typically available in 3-7 days

How our test process works!